Roche Holding AG
DUS:RHO
Roche Holding AG
DUS:RHO
Price:
360.4
EUR
0.33%
Market Cap:
€459.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Roche Holding AG
DUS:RHO
|
CH |
|
S
|
Salee Industry PCL
SET:SALEE
|
TH |
|
F
|
Fathom Nickel Inc
CNSX:FNI
|
CA |
|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
US |
|
Computer Age Management Services Ltd
NSE:CAMS
|
IN |
|
T
|
Tempus Holdings Ltd
HKEX:6880
|
HK |
|
Crescent Energy Co
NYSE:CRGY
|
US |
|
Sanwei Holding Group Co Ltd
SSE:603033
|
CN |
|
Ihara Science Corp
TSE:5999
|
JP |
|
Dnxcorp Se
PAR:ALDNX
|
LU |
|
Spartan Delta Corp
TSX:SDE
|
CA |
|
S
|
Shenzhen Dobot Corp Ltd
HKEX:2432
|
CN |
|
Z
|
Zhejiang Langdi Group Co Ltd
SSE:603726
|
CN |
Multiples-Based Value
The
Multiples-Based Value for
Roche Holding AG (RHO)
under the Base Case is
hidden
EUR.
Compared with the current market price of 360.4 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RHO Multiples-Based Value
LOCKED
Multiples Across Competitors
RHO Competitors Multiples
Roche Holding AG Competitors
Roche Holding AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Roche Holding AG
DUS:RHO
|
248.4B EUR | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
87.4B GBP | 2.7 | 15.3 | 8.3 | 10.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
